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1. Introduction
A patient-centered approach is recommended for the management of diabetes type 2 by the
American Diabetes Association and the European Association for the Study of Diabetes [1]
“These recommendations should be considered within the context of the needs, preferences,
and tolerances of each patient; individualization of treatment is the cornerstone of success.
(…). The implementation of these guidelines will require thoughtful clinicians to integrate
current evidence with other constraints and imperatives in the context of patient-specific
factors” [1. p. 1364]. It includes taking into consideration the variable and progressive nature
of type 2 diabetes, the specific role of each drug, the patient and disease factors that drive
clinical decision making, and the constraints imposed by age and comorbidity. This implies
diagnosis of psychosocial factors in regular medical practice. This is justified by sterling data
indicating that psychosocial factors have meaningful impact on the management of diabetes.
There is extensive literature suggesting that the patient’s mental state has a profound impact
on adherence to medical recommendations [2] and influences the course of the disease. Major
diabetic problems are more widespread among patients with clinical depression, than those
with subthreshold depression [3]. On the other hand, depression is more common among
people with diabetes than in general population [4], and even in its subclinical form, it increases
the risk of complications [5]. Research points to a link between the intensity of diabetes
treatment and the occurrence of depressive mood [2]. It also indicates that the course of the
disease affects the patient’s ability to cope with stressful situations [6] and sense of control over
the disease [7]. Many conducted studies reveal the importance of psychosocial factors in
diabetes self-care. Diabetes-related emotional distress is connected with difficulties with
diabetes self-management and poor glycemic control [8]. Self-efficacy and problem solving
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were associated with self-management behaviors like healthy eating and physical activity [9].
It is known that patients understand the importance of diabetes management and the conse‐
quences of bad metabolic control. Their poor control results not from a lack of knowledge but
on the way diabetes is prioritised in their lives [10]. There is evidence that diabetes manage‐
ment is strongly influenced by psychosocial factors [11]. This implies the necessity of inclusion
of diagnosis of psychological and psychotherapeutic factors during a routine visit of patients
with diabetes. Team approach in this management, including diabetologist, nurse, psycholo‐
gist, educator, and social worker is optimal. However, in many countries significant rates of
outpatient clinics can offer their patients therapeutic interventions made only by doctors and
the nurses. Working in such setting they need diagnositic and therapeutic tools helpful in
management of psychosocial problems related with diabetes. However, the number of tolls
that are useful in such conditions is limited. The computerized assessment tool “Monitoring
of Individual Needs in persons with Diabetes” (MIND) [12,13] includes World Health
Organization’s Five Well-being index (WHO-5) [14,15], Problem Areas In Diabetes (PAID)
[16-18], life events and patient’s agenda, can be used for diagnosis of psychosocial factors
connected to diabetes management. Analysis of data from the cross-national Diabetes Atti‐
tudes Wishes and Needs (DAWN) MIND study, conducted in 8 countries, also in our center
in Poland, confirmed that “MIND” computer procedure is feasible as a part of ongoing diabetes
care and helps to identify unmet psychosocial needs in diabetes patients. However it does not
help in psychotherapeutic diagnosis that is needed for the basic psychotherapeutic interven‐
tions that can be made by doctors during a regular visit[12,13]. The psychodiabetic KIT was
elaborated in response to such needs. The analysis of literature in MEDLINE and PUBMED
indicates that there are no concise comprehensive diagnostic tools for supporting psychother‐
apeutic diagnosis during the regular medical visit of patients with diabetes and there are no
simple psychotherapeutic strategies of interventions in such a setting. Psychodiabetic KIT
supports a diagnosis of coping styles, perception of self-influence on diabetes course and a
more reliable diagnosis of depression and anxiety, than the one WHO-5 and PAID used as
screening tools for depression. In this chapter we describe: a theoretical rationale of the
Psychodiabetic Kit, three tools that it comprises together with “The Practical Schema of
Psychotherapeutic Management within a Regular Medical Visit” as well as a review of research
confirming its usefulness both in research and clinical practice.
2. Rationale of psychodiabetic KIT
Improvement of patients’ adherence to the optimum management of diabetes may be consid‐
ered as the target of psychotherapeutic interventions during medical visits, when education
about the diabetes is not efficient. The theoretical framework of psychotherapeutic diagnosis
and interventions should be easy to understand for both therapists and patients. It was
presumed that due to the common time constrains the diagnostic tools should:
1. be brief
2. compromise goals of enhancing psychological thinking and psychometric proprieties
3. rather support the clinical psychological diagnosis, than replace it
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4. promote psychological understanding both of the patient and of the therapist
5. integrate the psychological diagnosis and interventions with the regular clinical manage‐
ment
Eventually the concept of coping with stress was chosen as theoretical background for the
diagnosis. Whereas the practical interventions following the recommendations of the Inter‐
national Diabetes Association [19] are based on philosophy of empowerment, and rule self-
management [19,20], that applies elements of behavioral therapy.
The concept of coping with stress related with diabetes and perception of self-influence on the
diabetes course
Coping is defined as ‘constantly changing cognitive and behavioral efforts to manage specific
external and/or internal demands that are appraised as taxing or exceeding the resources of
the person [21]. Coping is an adaptation activity that involves effort and aims to diminish the
physical, emotional, and psychological burden linked to stressful life events [22]. However,
the outcome of the coping process can also be maladaptation. The dispositional traits that
influence how stressful events are assessed and that consequently determine the strategies a
person uses to manage or address a stressor, may be described as coping strategies. Endler
and Parker [23] offered simple classification of coping styles: task-oriented, emotion-oriented
and avoidance-oriented. Patients utilizing an emotion- oriented strategy try to process
reactions to stressor(s) by acting and thinking and in this scenario the person is focused on the
emotion evoked by the stressor; overall, efforts are directed at altering the emotional responses.
Patients who use a task-oriented strategy believe that they can prevail the situation caused by
their disease or that they can adapt their resources to manage the situation, which often
involves taking direct action to alter the situation itself. An avoidance-oriented coping style
includes strategies such as avoiding a situation, denying its existence, or losing hope, via
conscious and/or unconscious mechanisms; when using this coping style, the person also uses
indirect efforts to adjust to stressors by distancing them, evading the problem, or engaging in
unrelated activities to reduce feelings of stress. In addition to emotion-, task-, and avoidance-
orientated, “the best solution oriented coping” style has been described [24]. When engaging
in the ‘identifying the best solution’ coping style, the person actively searches for the most
effective solutions, taking into account that they may be more “expensive” and risky than the
standard ones. The classification of coping styles into just four main categories simplifies the
understanding of these behaviors for both doctors and their patients. The concept of stress
introduced by Seyle [25,26] is commonly known, unlike its most important developments
dealing with the intensity of reactions to stressful events, that depends on [27] :
1. How the challenge is evaluated, what’s its meaning for the individual
2. Which coping style is used
3. What the level of social support is
Analysis of literature reveals a close relationship between an individual’s overall psychological
disposition and the cognitive and emotional aspects of their illness-coping strategies, which
indirectly affect health-seeking behaviors [28]. According to the goodness of fit hypothesis, the
effectiveness of problem- versus emotion-focused coping is moderated by appraisal of control
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over the stressful event [21,29]. The application of a problem-oriented coping style requires a
feeling of control over the stressor, while in situations where there is an actual or perceived
lack of control, an emotion-oriented or avoidance oriented coping style is applied. This concept
has received some empirical support in a study involving patients with type 2 diabetes mellitus
(T2DM) [30].
Indeed, among the variety of psychological factors described, the coping style and the
perception of control over the disease course seem to have an important effect on outcomes in
patients with diabetes [31,32]. Thus it is also likely that, in terms of coping strategies used to
deal with diabetes, the individual's appraisal of illness as controllable or uncontrollable plays
a role in the choice of strategy and therefore, ultimately, also in illness-associated outcomes.
In long-term progressive diseases, the concept of control is misleading because, in the majority
of cases, even total adherence to the recommended treatment regimen can not guarantee
restraining of either disease progress or recurrence of acute symptoms [7]. Perception of self-
influence on a disease course can be defined as the extent of belief about one’s own abilities to
shape the disease course. It was formulated in response to data indicating that the coping style
applied in response to a particular stressor is dependent on the perceived degree of control
over that stressor [7]. As such, the concept of perceived self-influence on the disease course
may be a more appropriate notion than control, when considering long-term progressive
diseases, as even with chronic diseases, adherence to the recommended treatment and
management plan can modify the disease course. Self influence also differs from perceived
self-efficacy, which is defined as beliefs about the capabilities to produce designated levels of
performance that exercise influence over events that affect lives. More specifically, self-efficacy
beliefs determine how people feel, think, behave and motivate themselves [28], while percep‐
tion of self-influence is related to disease management and is therefore more precise. Indeed,
perceived control of diabetes was found to be a significant predictor of engagement in diabetes-
specific health behaviors and positive perception of quality of life [31,32].
2.1. Depression and anxiety
Research analysis points to a high prevalence of depressive symptoms in a population of
patients with diabetes [4,33]. Depression and its subclinical forms are connected to a negative
course of diabetes. Depression is linked with poorer glicemic control [34]. Research confirms
higher mortality in those groups of patients, in which major or moderate depression was
diagnosed, when compared to a group in which depression was not found [35]. Moreover,
patients reporting higher intensity of depressive symptoms are less willing to talk to their
doctor about self-care [36]. Authors of the recent study, point that doctors need to be careful
for depressive symptoms in their patients, and suggests the usefulness of brief diagnostic tools
that may be used during a routine visit.
A higher prevalence of anxiety disorders and significant intensity of anxiety symptoms can
also be observed among patients with diabetes [37,38]. The occurrence of those symptoms is
connected to a poorer quality of life in diabetes patients [39]. The referred studies justify the
purposefulness of evaluating depression and anxiety in patients with diabetes.
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2.2. Description of the psychodiabetic KIT
Psychodiabetic KIT is a concise method of psychotherapeutic diagnosis and interventions
aiming at improving the patient’s adherence to therapeutic regimen. It was comprehensively
described in a series of manuals [40-44] widely distributed among Polish diabetologists. Its
application was discussed during many workshops. The Psychodiabetic Kit consists of:
1. Brief Methods of Evaluating Coping with Disease;
2. Brief Measure to Assess Perception of Self-Influence on the Disease Course: Version for
Diabetes;
3. Brief Self-Rating Scale of Depression and Anxiety;
4. The Practical Schema of Psychotherapeutic Management within a Regular Medical Visit
The Brief Method of Evaluating Coping with Disease (BMECD; published in the appendix)
[24] was created to assess the main four coping styles factors, which were mentioned above.
This questionnaire consists of four questions with a choice of four behaviors. Each response
relates to one of four distinguished coping styles related to aspects of life that are important
for patients with diabetes (interpersonal, social, economic, and health related matters). The
four BMECD questions are an outcome of a focus group interview with patients with T2DM
who, in the opinion of their doctors, had developed either adaptive or maladaptive styles in
order to cope with their disease. Data from the focus group were used by psychology students
working on their Masters theses to generate 16 questions that related to typical methods of
dealing with stressful situations according to each of the four main established coping styles.
These 16 questions were correlated with the scores of the Coping Inventory for Stressful
Situations (CISS) [45], the choice of the final four items was based on these results and on the
opinion of two experienced clinical psychologists from the Medical University of Warsaw. Due
to clinical observations indicating gender difficulties in perception and interpretation of some
examples used in the questionnaire, which resulted in the reliability not being as satisfying as
expected, the final version of BMECD [6] was elaborated. The changes included the descrip‐
tions of stressful situations adjusted to gender and to Polish language spelling by creating
separate versions for males and females, and to making the test easier to read. The gender
adjusted version has a relatively good reliability, as for an only four item questionnaire,
designed for screening for maladaptive coping and as for an educational tool. Cronbach’s
alpha= 0.67 for avoidance oriented coping style; 0.68 for emotion oriented style; 0.75 for task
oriented style; 0.59 for the best solution oriented style in the male version and respectively:
0.65; 0.67; 0.71; 0.55 in female version. The validity of the BMECD was assessed with the Polish
version of the CISS questionnaire [45] among 125 women and 104 men only. The strongest
correlations were found between: found between task-oriented coping style in CISS and
combined results for the task oriented and the best-solution oriented coping style in BMECD
among women (r = 0.42; p < 0.001) among men (r = 0.41; p < 0.001) and between scores in the
emotion oriented coping (r=0.29; p < 0.001 both for men and women). There were no significant
correlations between scores in avoidance oriented coping styles in both measures, both in
group men and women. Those correlations indicate that the coping styles identified in BMECD
have some similarities with those differentiated by CISS, but measure different modes of
reaction to stressful events.
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The Brief Measure to Assess Perception of Self-Influence on the Disease Course: Version for
Diabetes (BMAPS-IDC, published in the appendix)[7]. The BMAPS-IDC questions were
developed based on methodology that was discussed during a focus group interview with
patients with T2DM who, in the opinion of their doctors, had developed either adaptive or
maladaptive styles in order to cope with their disease. This led to the originating of 50 items,
each using a 5-point Likert scale to assess outcomes. These 50 items were then modified
following a discussion with two persons with diabetes. To further validate the 50-item version
of the BMAPS-IDC, the questionnaire was used among 170 patients, in whom their doctor,
using clinical judgment, rated the patient’s perception of self-influence on the diabetes course.
Statistical analysis (Wald test and logistic regression) identified six items that optimally
differentiated the group in terms of high and low perception of self-influence on the disease
course; thus, the final BMAPS-IDC questionnaire consisted of six items, each presented using
a 5-point Likert scale. Higher BMAPS-IDC scores denote a greater perception of self-influence
over the disease course.
The BMAPS-IDC has good reliability (Cronbach’s alpha, 0.75) and acceptable validity (Kendall
tau, 0.54), as well as a standardized ten scale for the assessment of results, which was created
to describe clinically significant differences. According to the ten scale, low raw scores of 0–11
scores correspond with <5 on the ten scale, average raw scores of 12–15 correspond to ten scale
scores of 5–6, and high raw scores of 16–24 of translate to 7–10 on the ten scale. There were no
meaningful gender differences in scores on this scale. In a study among 655 females and 544
males the mean score in BMAPS-IDC was 14.88 (SD= 4.332) and 14.11 (SD = 4.348) respectively.
This difference was statistically significant t = - 3.04, df=1193, p = 0.002, but was not clinically
significant [46].
A Brief Self-Rating Scale of Depression and Anxiety (BS-RSDA) [47]. It is a short method for
evaluating the intensity of depression and anxiety symptoms, developed with norms for
patients with diabetes. It consists of 10 items with an 11 degree Likert scale (from 0 to 10). The
overall score therefore falls somewhere between 0 to 100. 5 questions fall in the depression
category, 5 into the anxiety one (the result is from 0 to 50 for each of the scales). Construction
of these scales was based on most significant psychopathological symptoms characteristic for
depression in both classifications – DSM-IV and ICD 10. In the depression scale the following
factors were developed: mood, intensity of energy, strength of interests, ability to feel pleasure,
speed of thought and action. They constitute elements of depression episode and might appear
in other depressive disorders. In case of anxiety there are many categories of anxiety disorders.
For the evaluation of anxiety symptoms, the following factors were included: 1. worry, tension,
uneasiness; 2. anxiety or fear of specific threat; 3. apprehension, distress; 4. physical tension;
5. desire to avoid situations that cause anxiety.
The tool has good psychometric properties, evaluated on the basis of a study conducted on
240 respondents – patients with diabetes. Both scales proved to have good reliability, the
Cronbach’s alpha was 0.95 for depression and 0.94 for anxiety. Both scales were also found to
be valid. The depression scale correlated with the results of Beck Depression Inventory
(r=0.809) and the HADS Depression Scale (r=0.797). The anxiety scale correlated with the results
of HADS Anxiety Scale (r=0.805). Reliability of the entire scale was also high (Cronbach’s
alpha=0.956). Because of the lack of a reference tool, the validity of the whole scale was not
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measured. High reliability of the subscales was replicated in a study among 101 persons with
diabetes: Cronbach’s alpha was 0.92 for the depression scale and 0.91 for the anxiety scale. In
the study among 133 persons with cardiologic and orthopedic disease in the test-retest
reliability measurement, after 30 minutes, the correlation of subscale scores for depression was
r=0.845, and for the subscale of anxiety r=0.814
A temporary ten norm scales were developed, and the analysis of relations of the BS-RSDA
scores and diagnosis of depression with structured interview indicated that results of depres‐
sion subscale >11 have sensitivity for detection of depression that is 0.886 and specificity that
is 0.727.
2.3. The practical schema of psychotherapeutic management within a regular medical visit
[40,44,48]
The schema was created in order to help doctors in making basic psychotherapeutic interven‐
tions during the regular visit. Its application was encouraged by series of workshops for
doctors treating diabetes in Poland, however it may be used without the training. The main
goals of this intervention is helping patients in the stressful problems related with diabetes.
The diagnosis focuses on the assessment and practical teaching patients about coping mech‐
anisms, perception of self-influence on the diabetes course and development of patient abilities
of problem-solving and use of coping task oriented and “the best solution oriented” coping
styles. It eventually broadens the range of behaviors aiming at problem solving. This is
congruent with self-management with diabetes based on empowerment. The study [49] shows
that a mere transfer of information between the doctor and the patient (regarding the disease
and the proposed treatment) does not ensure satisfactory results in terms of the outcome of
treatment and the patient’s adherence to medical recommendations. An improvement on the
doctor-patient relationship has been suggested, basing on the tenets of cognitive behavioral
therapy. The traditional model in which the health-care provider is the 'expert' to be consulted
by the 'patient' has been replaced by a partnership in which both parties cooperate to achieve
best results. In this approach, the patient is the central figure and – acknowledged to be an
expert in his/her problematic symptoms - becomes an active member of his/her disease
management team. The role of the therapist, on the other hand, is to assist the patient in this
process. One of the methods which can be employed by the therapist is the Socratic method
in the form of Socratic dialog that enables the patient to determine the problem areas and to
guide them to make decisions regarding the course of treatment. Instead of offering ready
solutions the therapist is required to guide the patient to work out the solutions to their
problems. Thus the patients are empowered to use their own initiative, which shifts the locus
of control closer to them and motivates them to effectively manage their own care leading to
significant improvements in healthy behavior. In order to achieve this, cognitive behavioral
therapy recommends the method of “small steps” whereby the patient is encouraged to make
gradual alterations in their habits rather than introduce radical changes. Even modest results
serve as positive reinforcement and motivate further efforts. The Schema consists of the
following steps:
1. Welcoming and establishing contact.
Psychodiabetic Kit and Its Application in Clinical Practice and Research
http://dx.doi.org/10.5772/56468
513
– doctor’s warm attitude towards the patient
– giving the patient a chance to say what he/she really wants to say
– It is crucial that the doctor establishes good contact with the patient so that the patient feels
comfortable enough to confide in the doctor.
2. Discussing the implementation of the last homework.
– realistic estimation of achievements
– realistic estimation of difficulties
When assessing the degree to which the patient succeeded in complying with the doctor’s
recommendations it is important to ask open questions so as not to exert pressure on the patient
or make them feel examined. In order to empower the patient, the doctor needs to appreciate
any effort on the part of the patient and analyze any difficulties with which they may be
struggling.
3. Setting the goals of the present visit
– asking the patient what he/she would most like to discuss
– in case of problems with making the choices:
• placing the possible goals in order,
• dividing very difficult goals into smaller ones (“step-by-step” approach)
– in case of serious problems in everyday life - adjusting the therapeutic goals to the to this
circumstances
The goal which the patient is to pursue, ought to be realistic, specific (clearly defined) and
measurable. In establishing the goal, the patient’s current problems need to be considered,
including non-medical ones, and assess their impact on the illness. If it is needed, the doctor
is recommended to suggest taking small steps, which means breaking the goal down into
smaller, more achievable goals. This will enhance the chances of success.
4. Medical examination
– adjustment of the set up goals to an outcome of the medical examination and conducting the
required diagnostic procedure
The goals need to be established in the context of the patient’s general condition. Only after
examining the patient appropriate steps can be set.
5. A brief medical psychotherapeutic diagnosis
– screening for depression and anxiety
It may be made with A Brief Self-Rating Scale of Depression and Anxiety or any other
diagnostic tool. The patients identified with risk of depressive disorders or anxiety disorders
should be referred for a psychiatric consultation.
– dominating style of coping with stress related with the disease
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– the feeling of the influence on the course of the disease
The coping style and perception of self-influence on the diabetes course may be made with
use of aforementioned. The physician needs to assess how ready the patient is to introduce
changes in his/her lifestyle, how strongly he/she believes in the positive outcome of the changes
and to what degree the patient feels he/she has the perception of self-influence on a particular
problem.
6. Socratic dialog leading to a realistic evaluation of the main problem’s source and its
possible solutions
– assessment of the problem in the context of general life situation
–formulation of possible solutions
– assessment of advantages and disadvantages of possible solutions
Asking the patient a series of questions enables him/her to determine the source of the problem
and to seek the most suitable solution. Since the patient is encouraged to use their own
initiative, they will more strongly believe in their ability to achieve their goals.
7. Setting the realistic homework for the period prior to the next visit.
– “small steps” that have good chance for successful outcomes
– defining the criteria of the outcome estimation
– formulating actions that will be taken in case of serious problems with conducting homework
On the basis of the information gathered during the visit, the doctor is recommended to work
out a list of recommendations to be implemented by the patient after the visit. It is important
to consider any foreseeable difficulties and discuss the means to overcome them.
8. Recapitulation of the visit by the patient
– what are the conclusions of the discussion
– what is the homework to be conducted prior to the following appointment
It is good if the physician asks the patient to recapitulate briefly to make sure that the patient
understands the arrangements discussed during the visit
3. Discussion
The Psychodiabetic KIT was created in order to encourage doctors to make psychotherapeutic
diagnoses and basic psychotherapeutic interventions that will improve their patients’ coping
with diabetes. Realistically, it may be helpful during a yearly follow up visit, that according
to International Diabetes Federation guidelines [19] should include assessment of psycholog‐
ical functioning of patients with diabetes type 2 or when screening tools or clinical assessment
indicate a risk of psychological problems related to diabetes, including comorbid depression
or anxiety disorders. The diagnostic tools can be used together or separately. However, it is
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recommended that the doctor or the nurse using the KIT become familiar with the details of
The Brief Method of Evaluating Coping with Disease and are able to use examples of situations
and reactions specific for the four main coping styles, in the process of educating the patient
about his/her coping styles and, if needed, possibilities of its improvement. It may also be
helpful for the patient to get a copy of the questionnaire with the key. It is crucial to explain
to the patient that his/her perception of self-influence on the disease course, explain the need
for the development by him/her the task oriented coping and the best solution oriented coping
for dealing with diabetes related stressful problem. The patients with low level of the percep‐
tion of self-influence on the disease course need interventions increasing this aspect of illness
perception. It includes the “step-by-step” approach to the diabetes related problem together
with self-monitoring effects of activity by making written records or self-rating scales.
Otherwise, nonadherence to many of therapeutic recommendations among patients with a
low perception of self-influence on diabetes course is very likely. Brief Self-Rating Scale of
Depression and Anxiety needs specific norms for each language. However, the Polish sten
norms can be helpful in a preliminary assessment of the intensity of symptoms of depression
and anxiety(detailed ten norms are available from the first author).
They may also be used for the comparison of those symptoms in time. The version of the
Psychodiabetic KIT tools included in the Appendix followed the rules of back-translation as
it is a commonly accepted methodology in such cases. Still, their psychometric proprieties
should be assessed in English speaking countries. Translations into other languages need back-
translation procedures and assessment of their psychometric proprieties, before application
in research. The main idea of the Psychodiabetic KIT is to facilitate clinical diagnosis, psycho‐
education of the patient considering coping, perception of self-influence as well as the need
for monitoring depression and anxiety. Even non-validated translations of the KIT may be
helpful in reaching these goals.
4. Application of the components of psychodiabetic KIT in research
Components of Psychodiabetic KIT were used in several research. This review presents only
those which were published, including two cross-sectional, national studies. However, the
results of other studies that resulted in on Ph. Thesis, and more than 10 M.A. thesis are currently
in process of preparation for publications.
The national, cross- sectional study “Relationship between psychological coping style and
insulin pen choice in patients with T2DM” [50] was aiming at assessment of relationship among
coping styles and a choice of one of four available pens – insulin injectors that differed in
technological complexity, size and accuracy:
• InnoLet – big and disposable, filled with insulin
• NovoLet – small and disposable; filled with insulin
• NovoPen 3 – durable, for multiple use, and filled each time by the patient
Innovo – durable, for multiple use, compact size, that make discretely injection in social
situations possible, as well as record of the dosage and time of injection. The study was
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conducted by general practitioners with subsequent patients and only included a single visit
during which treatment with insulin was initiated and when the patient chose an insulin
injector. The style of coping was assessed at the same time with the working version of The
Brief Method of Evaluating Coping with Disease (BMECD)[24], that had worst psychometric
proprieties, assessed on smaller group that final one). The study involved 945 patients (553
females [59.1%]; 382 males [40.9%] – gender data were missing for 10 patients) aged 18–90
years (mean [SD]: 61.7 [11.7] years) who were beginning insulin therapy after a period of
treatment for T2DM ranging from several months to 61 years (mean [SD]: 8.3 [5.9] years). The
number (proportion) of patients in this study choosing each type of pen was: 460 (48.7%)
NovoPen® 3; 269 (28.5%) NovoLet®; 25 (2.6%) Innovo®; 176 (18.6%) InnoLet®; data were missing
for 15 (1.6%) patients. Statistically significant differences between mean BMECD scores were
found among patients who chose one of four types of insulin pens. The results indicated that
an avoidance-oriented coping style was associated with choosing the simplest insulin pen, an
emotion-oriented coping style with a more complicated insulin pen, a task-oriented coping
style with a modern pen, and the ‘the best solution oriented’ coping style with the technolog‐
ically most advanced pen. In spite of many methodological limitations of this study its results
encouraged the elaboration of the final version of the BMECD and supported its usefulness in
clinical practice.
Another cross-sectional national study [46] involved 480 physicians and 1199 patients (655
females [54.6%]; 544 males [45.4%]) aged 4–93 years (mean [SD]: 62.0 [11.6] years) who were
beginning insulin therapy after a period of treatment for diabetes ranging from several months
to 36 years (mean [SD]: 8.0 [5.5] years). The study was conducted with consecutive patients
and only included a single visit during which treatment with insulin was initiated and when
the patient made their choice of insulin injector. Analysis of the relationship between the
perception of self-influence on the disease course and choice of insulin pen was possible for
1184 (98.7%) persons enrolled in the study. The Brief Measure to Assess Perception of Self-
Influence on the Disease Course: Version for Diabetes (BMAPS-IDC) was applied. The number
(proportion) of patients in this study choosing each type of pen was: 538 (44.9%) NovoPen® 3;
383 (31.9%) NovoLet®; 220 (18.4%) InnoLet®; data were missing for 58 (4.8%) patients. In the
group that chose the simplest disposable injector – InnoLet® – the mean BMAPS-IDC score
(12.23) was significantly lower than in group that chose the smaller and more complicated type
of injector (NovoPen® 3, 15.72). The mean BMAPS-IDC score in the group that chose the
intermediate injector (NovoLet®, 13.88) lay between, and was statistically different from, the
means of the other two groups.
Of the 395 patients in this study with data from relevant assessments, mean HbA1c levels were
≤6.5% (low risk of cardiovascular [CV] complications) in 10 (2.5%) patients; between 6.6 and
7.5% (risk of arterial complications) in 38 (9.6%) patients; and >7.5% in 347 (87.8%) patients.
Mean (SD) BMAPS-IDC scores in the groups with low risk of CV complications, risk of arterial
complications, and risk of microvascular complications were: 18.20 (2.97), 16.55 (4.38), 14.43
(4.35), respectively. The difference in BMAPS-IDC scores between the group at low risk of CV
complications (HbA1c ≤6.5%) and the group at risk of microvascular complications (HbA1c
>7.5%) was statistically significant (p<0.01).
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A correlation analysis suggested that the perception of self-influence on the course of diabetes
has an increasing impact on the effectiveness of the treatment, as assessed by HbA1c levels
following long-term treatment. In total, 72 patients had been treated for less than 3 years, 72
for 3 years or more, and 249 for more than 5 years. The correlations were not significant in the
group treated for diabetes for less than 3 years. Weak, but statistically significant correlations
were found in the group treated for more than 3 years for diabetes (r=-0.18; p<0.05) and for
those with a disease length over 5 years (r=-0.2; p<0.05).
Limitations of both of these studies include the observational design, which meant that
participating doctors were not blinded to the results and could potentially influence patients’
results. Due to the cross-sectional design the data presented in this paper only describe a
relationship between coping styles or the perception of self-influence on the disease course
and the type of device used at the beginning of insulin therapy, but cannot prove a cause and
effect relationship, which may be worthy of further investigation.
Studies, which were presented above, revealed that the coping style and perception of self-
influence on the course of diabetes have an important role in the process of the treatment
choice. The relationship between the perception of self-influence on the disease course and the
effectiveness of the treatment manifested by HbA1c level is also noteworthy.
Overall, the results of these studies indicate that psychological intervention aimed at devel‐
oping task-oriented and ‘the best solution-oriented’ coping styles may result in the choice of
more precise treatment, allowing more accurate glycemic control. Therefore, helping patients
understand and believe that they can control the outcome of their diabetes is of value.
Conversely, clinicians may wish to use these findings to help them identify the coping style
and the level of belief in self influence for a particular patient, which could enable further
individualization of the treatment plan.
Comparing coping styles, occurrence of depressive and anxiety symptoms, and locus of control
among patients with diabetes type 1 and type 2 in groups of 30 with type 1 and 27 with type
2 [51]. In the group of patients with diabetes type 2 there were found significantly higher, than
in diabetes type 1: emotion oriented coping style (M = 0.4; SD = 0.814 vs. M = 0.93; SD = 0.958;
p = 0.029), avoidance oriented coping style (M = 0.63; SD = 0.809 vs. M = 1.22; SD = 0.892; p =
0.011); level of depression (M = 4.13; SD = 2.662 vs. M = 5.63; SD = 2.911; p = 0.047), attribution
of the health control to a chance (M = 19.03; SD = 6.672 vs. M = 24.26; p = 0.004) and also lower
task-oriented coping style. (M = 1.8; SD = 1.095 vs. M = 1.07; SD = 0.829; p = 0.007).
What was also found, were the significant relations among the best solution-oriented coping
style, emotion oriented style and the level of anxiety (respectively r = - 0.373; r = 0.37) and level
of depression (respectively r = - 0.352 i r = 0.476); solution-oriented coping style, emotion-
oriented coping style, level of anxiety and with the attribution of the health control to a chance
(respectively r = 0.341; r = 0.271; r = 0.301); level of depression and locus of control (r = 0,322),
i.e.: higher level of depression is correlated with more external locus of control; attribution of
the health control to a chance and the older age (r = 0.407). The results of this preliminary study
suggests that patients with diabetes type 2 use more maladaptive coping styles (emotion and
avoidance oriented) than patients with diabetes type 1, and that use of specific coping styles
is related with depression and anxiety
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5. Assessment of psychodiabetic kit by doctors
In a survey conducted during a series of educational conferences in 2006, out of 217 doctors
treating patients with diabetes, approximately half of them were acquainted with the BMECD
and one-third with the BMAPS-IDC. In addition, 52.6% of doctors familiar with the BMECD,
reported using it in everyday practice, and the majority were keen to further develop their
experience with psychological tools used for the support of diabetic patients. [52]
6. Conclusions
1. Current guidelines of the International Diabetes Federation [19] and American Diabetes
Association [20] as well as consensus statement of the American Diabetes Association and
Europeans Association for Study of Diabetes, in respect to current knowledge, recom‐
mend individualized patient–centered approach in treatment and management of
diabetes type.
2. A team approach, including variety of medical professionals, is recommended by IDF [19]
on the “comprehensive” and ”recommended” levels of care. However, these guidelines
also describe a kind of “limited” care in respect to existence of “settings with very limited
resources – drugs, personnel, technologies and procedures” [19].
3. The Psychodiabetic KIT facilitates, brief psychotherapeutic diagnosis and education of
patients dealing with coping with diabetes related stressors as well as simply therapeutic
interventions based on currently recommended rules of self-management and empow‐
erment aiming at increasing the patients’ perception of self-influence on the diabetes
course and at the development of task related and “the best solution oriented” coping
with stressful problems. It also may be used for depressive disorders and anxiety disorders
screening.
4. The results of research indicate that the Brief Method of Evaluating Coping with Disease
and the Brief Measure To Assess Perception Of Self- Influence On The Disease Course are
useful in research. Their results confirm that coping styles and perception of self-influence
on the disease course are related with the choice of treatment modality, i.e. insuline
injector. The difference of the level of perception of self- influence on diabetes course was
statistically significantly higher in between the group at low risk of CV complications
(HbA1c ≤6.5%) than in the group at risk of microvascular complications (HbA1c >7.5%).
There were also week, but statistically significant correlations between the perception of
self-influence on the course of diabetes, the effectiveness of the treatment, as assessed by
HbA1c levels in groups of treated patients. The results of the preliminary study suggest
that patients with diabetes type 2 use more maladaptive coping styles (emotion and
avoidance oriented) than patients with diabetes type 1, and that a use of specific coping
styles is related with depression and anxiety.
5. The results of anonymous survey among Polish doctors treating diabetes indicate that
Psychodiabetic KIT may by useful in everyday practice.




Brief method of evaluating coping with disease1: Version for men (Kokoszka, Radzio, Kot,
2008)
Name…………………………………………..Date……………………………..
Please circle one answer to each of the four questions:
1. If you found yourself in a group of people having to deal with a serious problem (among people
shamed by a building society authorities or a service company not meeting its obligations), you
would most probably:
a. Do nothing and count on someone else to take care of it or would figure out that its pointless
and dealing with it is a waste of time
b. Look for others who were harmed and, together with them, try to protect my rights
c. Try to influence the people who got engaged in solving the problem, so that I could get the
best outcome
d. Be mainly angry and upset and would not feel like doing anything
2. When you notice longer-lasting swerves in your health (minor pain, weakness), you usually:
a. Not worry for a while and wait for them to pass
b. Worry that it might be a beginning of a serious illness, which may potentially cause
problems
c. Look for information in a health-guide, ask acquaintances who have had similar problems
or contact a doctor
d. Contact a doctor as soon as possible and want to do everything possible to prevent the
development of the disorder or at least assuage its course
3. If you had a chance to inherit, but it required a long-drawn participation in a trial, you would
probably:
a. Decline participation as not being sure about the success you wouldn’t want to waste time
on unpleasant activities
b. Lodge a lawsuit yourself
c. Hire a lawyer to best represent your interest
d. Be irritated by the situation and ask relatives or friends to take care of it
4. When there is a serious conflict between your close-ones, you usually:
a. Try talking to them in order to resolve the conflict
b. Do nothing and try to avoid thinking about it
c. Feel upset and worries because I don’t like situations like that
d. Try to link them to others who had similar problems or talk to them about how others
handled similar situations
1 The authors gratefully acknowledge permission to translate this method to Via Medica, that published paper: Kokoszka
A, Radzio R, Kot W. Krótka Metoda Ocena Radzenia Sobie z Chorobą: wersja dla mężczyzn i kobiet (Brief Method of
Evaluating Coping with Disease: versions for men and women). Diabetologia Praktyczna 2008;9(1) 1-11.
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Brief method of evaluating coping with disease: Version for women (Kokoszka, Radzio,
Kot, 2008)
Name…………………………………………..Date……………………………..
Please circle one answer to each of the four questions:
1. If you found yourself in a group of people having to deal with a serious problem (with young
people disturbing peace in your community, with your superior at work or with the authorities
of a building company), you would most probably:
a. I would try to engage in some other activity and wait patiently, believing that that the
problem will be solved
b. Engage in the activities of the group trying to solve the problem
c. Try to influence the people who got engaged or lead them myself, but mainly I would try
to solve the problem in the best option for me
d. Be mainly angry and upset and would not feel like doing anything
2. When you notice longer-lasting swerves in your health (minor pain, weakness), you usually:
a. Hope, they are not serious and wait for them to pass
b. Worry and are afraid of different possible illnesses
c. Look for information in a health-guide, ask acquaintances who have had similar problems
or contact a doctor
d. Contact a doctor as soon as possible and want to do everything possible to prevent the
development of the disorder or at least assuage its course
3. If you had a chance to inherit, but it required a long-drawn participation in a trial, you would
probably:
a. Resign your participation
b. Lodge a lawsuit yourself
c. Hire a lawyer to best represent your interest
d. Be worried by the need of participating in the procedure and rely on my relatives’ opinions
4. When there is a serious, prolonged conflict between your close-ones, you usually:
a. Try talking to them in order to resolve the conflict
b. Do nothing and try to avoid thinking about it
c. Feel upset and worried and want them to solve it as quickly as possible
d. Try to assess whether they need help and what I could do to offer best possible support
Key for interpreting answers
Versions for both gender
Find each of the patient's answer on the list below then calculate the number of the respons‐
es characteristic for each of four coping styles. This result can be discussed with the patient
and the answers characteristic for each of the coping style can be used for the patient educa‐
tion on coping styles. In research, row results are used.
Task-oriented coping style
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1. b) look for others who were harmed and, together with them, try to protect my rights/ engage
in the activities of the group trying to solve the problem
2. c) look for information in a health-guide, ask acquaintances who have had similar problems or
contact a doctor
3. b) lodge a lawsuit yourself;
4. a) try talking to them in order to resolve the conflict
Best solution-oriented coping style
1. c) try to influence the people who got engaged in solving the problem, so that I could get the
best outcome/ try to influence the people who got engaged or lead them myself, but mainly I
would try to solve the problem in the best option for me
2. d) contact a doctor as soon as possible and want to do everything possible to prevent the
development of the disorder or at least assuage its course
3. c) hire a lawyer to best represent your interest
4. d) try to link them to others who had similar problems or talk to them about how others handled
similar situations/ try to assess whether they need help and what I could do to offer best possible
support
Emotion-oriented coping style
1. d) be mainly angry and upset and would not feel like doing anything
2. b) worry that it might be a beginning of a serious illness, which may potentially cause problems/
worry and are afraid of different possible illnesses
3. d) be irritated by the situation and ask relatives or friends to take care of it/ be worried by the
need of participating in the procedure and rely on my relatives’ opinions
4. c) feel upset and worries because I don’t like situations like that/ feel upset and worried and
want them to solve it as quickly as possible
Avoidance-oriented coping style
1. a) do nothing and count on someone else to take care of it or would figure out that its pointless
and dealing with it is a waste of time/ I would try to engage in some other activity and wait
patiently, believing that that the problem will be solved
2. a) not worry for a while and wait for them to pass/ hope, they are not serious and wait for them
to pass
3. a) decline participation as not being sure about the success you wouldn’t want to waste time on
unpleasant activities/ resign your participation
4. b) do nothing and try to avoid thinking about it
The sum of given answers
Task-oriented coping style – ….
Best-solution oriented coping style –....
Emotion-oriented coping style –....
Avoidance-oriented coping style –....
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Brief measure to assess perception of self- influence on the disease course (Kokoszka, 2005)2
Name…………………………………………..Date……………………………..
Please circle your personal opinion on each of the following questions:
1. If I take care of myself, I will have a better health
 
I fully agree  I rather agree  It is hard to say   I rather disagree   I disagree 
2. If I accomplish all my plans related to the management of diabetes (treatment, diet, physical
activity) I generally feel relief
 
I fully agree  I rather agree  It is hard to say   I rather disagree   I disagree 
3. I spend a lot of time preventing possible future complications of my illness
 
I fully agree  I rather agree  It is hard to say   I rather disagree   I disagree 
4. Diet and lifestyle do not influence my health, because the most important is medication
(and insulin)
 
I fully agree  I rather agree  It is hard to say   I rather disagree   I disagree 
5. The course of my illness depends mostly on fate
 
I fully agree  I rather agree  It is hard to say   I rather disagree   I disagree 
6. The experience gained during therapy helps me to better cope with other problems in my
life
 
I fully agree  I rather agree  It is hard to say   I rather disagree   I disagree 
2 The authors gratefully acknowledge permission to translate this method to Wydawnictwo Przegląd Lekarski that
published the paper: Kokoszka A. Krótka metoda oceny poczucia wpływu na przebieg choroby: opis wersji dla osób z
cukrzycą (Brief measure to assess perception of self-influence on the disease course. Version for diabetes).Przegląd
Lekarski 2005;62(8) 742-745




Questions 1, 2 ,3, 6 Questions 4, 5 – inverted score
I fully agree – 4 I fully agree – 0
I rather agree – 3 I rather agree – 1
It is hard to say – 2 It is hard to say – 2
I rather disagree –1 I rather disagree – 3
I disagree – 0 I disagree – 4
Interpretation according to standardized ten scale:
Low scores 0-11( < 5 sten)
Average scores 12-15 (5-6 sten)
High scores 16-24 (> 6 sten)
Brief Self- rating scale of depression and anxiety (Kokoszka, 2008) 3
Name…………………………………………..Date……………………………..
Please assess your well-being on the following scales by putting an X in a chosen place of
the scale.
You should compare your current well-being with previous feeling of comfort.
Number 10 stands for an intensity of the assessed feature that is the highest that you can
imagine.
1. Mood
0 1 2 3 4 5 6 7 8 9 10 
 
good   moderate sadness              sadness   intense sadness   severe sadness 
 
2. Intensity of energy
2. Intensity of energy 
0 1 2 3 4 5 6 7 8 9 10 
 
good intensity   moderate lack    considerable lack   great lack    complete lack  
of energy  of energy   of energy   of energy   of energy 
 
3 The authors gratefully acknowledge permission to translate this method to Termedia, that published, the paper:
Kokoszka A. Krótka Skala Samooceny Depresji i Lęku: opis konstrukcji oraz właściwości psychometrycznych dla osób
z cukrzycą (Brief Self-Rating Scale of Depression and Anxiety: description of the scale construction and psychometric
proprieties for persons with diabetes). Przewodnik Lekarza 2008;11(6) 74-81
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3. Power of interests
0 1 2 3 4 5 6 7 8 9 10 
 
normal   moderately weakened considerably weakened  highly weakened             severely weakened 
 
4. The capacity to feel pleasure
0 1 2 3 4 5 6 7 8 9 10 
 
normal   moderately weakened considerably weakened  highly weakened             severely weakened 
 
5. Speed of thought and action
0 1 2 3 4 5 6 7 8 9 10 
 
normal   moderately weakened considerably weakened  highly weakened             severely weakened 
 
6. Worry, tenseness, nervousness
6. Worry, tenseness, nervousness 
0 1 2 3 4 5 6 7 8 9 10 
 
none    moderate   strong   very strong   severe 
 
7. Anxiety (feeling of fear without a certain reason), fear of a specified threat
6. Worry, tenseness, nervousness 
0 1 2 3 4 5 6 7 8 9 10 
 
none    moderate   strong   very strong   severe 
 
8. Apprehension and distress about something that might happen
6. Worry, tenseness, nervousness 
0 1 2 3 4 5 6 7 8 9 10 
 
none    moderate   strong   very strong   severe 
 
9. Feeling of physical tension in a body (intense muscle tension, trembling hands, aches)
6. Worry, tenseness, nervousness 
0 1 2 3 4 5 6 7 8 9 10 
 
none    moderate   strong   very strong   severe 
 
10. Desire to avoid situations that cause anxiety (hiding, withdrawing)
6. Worry, tenseness, nervousness 
0 1 2 3 4 5 6 7 8 9 10 
 
none    moderate   strong   very strong   severe 
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Key — Adding the scores 1-5 depression subscale; 6-10 anxiety subscale
Reliability: depression scale α Cronbacha= 0,95; anxiety scale α Cronbacha= 0,94, entire scale
α Cronbacha=0,956.
Interpretation according to standardized ten scale:
Depression scale:
Low scores 0-2 (1–4 sten)
Average scores 3-12 (5–6 sten)
High scores 13-50 (7–10 sten)
Anxiety scale:
Low scores 0-4 (1–4 sten)
Average scores 5-14 (5–6sten)
High scores 15-50 (7–10 sten)
Entire scale:
Low scores 0-8 (1–4 sten)
Average scores 9-27 (5–6 sten)
High scores 28-100 (7–10 sten)
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